• Director, Sumiran Womens Hospital and FOGSI Recognized Radhe Endoscopy Training Centre & Research Institute, Ahmedabad, Gujarat.
• Director, FOGSI Recognized Radhe Endoscopy Training Centre & Research Institute, Mehsana, Gujarat.
• Dr Mehul Sukhadiya works as Laparoscopic Gynec- Surgeon since last 20 years.
• Area of interest is difficult T.L.H, Tuboplasty, Sacropexy, Myomectomy, fertility sparing endometriosis surgery and other complicated cases.
• Credit for doing bloodless T.L.H in 25-35 min.
• Designed & Patented " SUKHADIYA MANIPULATOR ® ".
• Published ENDO EASY Booklet for beginners in gynaecological endoscopy.
• Shortly going to release Jaypee’s MINI ATLAS series of " GOLD STANDARD TECHNIQUES OF T.L.H ".
• Done more than thousand number of T.L.H and thousand number of Laparoscopy Surgeries.
• Has trained more than 550+ doctors all around India.
• Visiting Surgeon at more than 55 centers in Gujarat and other states.
• Invited as a Faculty in the State, National and International Workshop and Conferences.

• ISAR(Indain Society for Assited Reproduction)
• FOGSI (Federation of Obstetric & Gynaecological Society of India)
• IAGE (Indian Association of Gynaecological Endoscopist)
• ISGE (International Society for Gynecologic Endoscopy)
• AAGL (American Association of Gynecologic Laparoscopy)
• Dr Mehul Sukhadiya has credit of designing a world class manipulator, for doing Total Laparoscopic Hysterectomy with ease. The designed manipulator has a registered patent.

M.B., D.G.O. (USA, Germany)
IVF Specialist and Consultant Endoscopic Surgeon Director

Sumiran Womens Hospital, Ahmedabad
Director
Radhe Endoscopy Training Centre & Research Institute Gold Standard Technique of Total Laproscopic Hystrectomy

• The first Indian Doctor to receive the Award of Excellence from Richard Wolf Germany is Dr. Mehul Sukadiya (Sumiran Woman’s Hospital).
• Gold Standard Tehnique of Total Laprascopic Hysterectormy – book published by Dr. Mehul Sukadiya Dr. Mehul Sukadiya (Sumiran Woman’s Hospital).
• 1st IVF baby 10th August 2010 with more than 3000 similar ongoing cases.